- Home
- YSXT vs INMB Comparison
YSXT vs INMB Comparison
Compare YSXT & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YSXT | INMB |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | China | United States |
| Employees | 39 | N/A |
| Industry | Automotive Aftermarket | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.5M | 34.3M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | YSXT | INMB |
|---|---|---|
| Price | $1.25 | $1.25 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.40 |
| AVG Volume (30 Days) | 197.9K | ★ 354.0K |
| Earning Date | 02-03-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $50,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $5.57 | ★ N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $1.03 | $1.09 |
| 52 Week High | $9.90 | $11.64 |
Technical Indicators
Market Signals| Indicator | YSXT | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 50.10 | 48.63 |
| Support Level | $1.08 | $1.21 |
| Resistance Level | $1.47 | $1.48 |
| Average True Range (ATR) | 0.09 | 0.08 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 77.72 | 67.39 |
Price Performance
Historical ComparisonAbout YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.